Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

63.90
Delayed Data
As of Jul 31
 -0.87 / -1.34%
Today’s Change
18.75
Today|||52-Week Range
77.73
+49.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues61.2M85.4M80.9M124.4M
 
 
 
 
 
Cost of Goods Sold8.0M10.0M10.8M13.3M
 
 
 
 
 
Depreciation And Amortization2.5M3.1M1.2M7.0M
 
 
 
 
 
 
Operating ExpensesGross Income50.7M72.3M68.9M104.1M
 
 
 
 
 
General Expenses127.0M84.8M76.0M97.1M
 
 
 
 
 
Research And Development58.1M33.3M20.6M24.2M
 
 
 
 
 
Total Operating Expenses137.5M97.9M88.0M117.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-76.3M-12.5M-7.1M7.0M
 
 
 
 
 
Extraordinary Credit0.000.00--681.0K
 
 
Extraordinary Charge-3.5M-4.9M-4.5M-11.5M
 
 
 
 
 
Interest Expense On Debt0.000.00--14.7M
 
 
Other Expenses-193.0K-1.5M964.0K217.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-78.2M-17.6M-9.6M-17.3M
 
 
 
 
 
Income Taxes-1.2M-854.0K0.00-153.2M
 
 
 
 
Net Income-77.1M-16.8M-9.6M135.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.2M21.4M21.7M22.4M
 
 
 
 
 
Shares To Calculate EPS Diluted21.2M21.4M21.7M25.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.64-$0.78-$0.44$5.45
 
 
 
 
 
EPS Diluted-$3.64-$0.78-$0.44$5.38